USS Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.59M | Hold |
26,366
| – | – | 0.05% | 234 |
|
|
2025
Q1 | $7.12M | Hold |
26,366
| – | – | 0.05% | 254 |
|
|
2024
Q4 | $6.21M | Sell |
26,366
-6,505
| -20% | -$1.53M | 0.04% | 332 |
|
|
2024
Q3 | $9.04M | Sell |
32,871
-3,976
| -11% | -$1.09M | 0.07% | 266 |
|
|
2024
Q2 | $8.96M | Buy |
36,847
+1,433
| +4% | +$348K | 0.07% | 226 |
|
|
2024
Q1 | $5.29M | Buy |
35,414
+3,712
| +12% | +$554K | 0.04% | 370 |
|
|
2023
Q4 | $6.07M | Sell |
31,702
-2,529
| -7% | -$484K | 0.05% | 312 |
|
|
2023
Q3 | $6.06M | Buy |
34,231
+4,206
| +14% | +$745K | 0.07% | 307 |
|
|
2023
Q2 | $5.71M | Hold |
30,025
| – | – | 0.07% | 320 |
|
|
2023
Q1 | $6.01M | Sell |
30,025
-1,209
| -4% | -$242K | 0.08% | 285 |
|
|
2022
Q4 | $7.42M | Sell |
31,234
-45,569
| -59% | -$10.8M | 0.1% | 225 |
|
|
2022
Q3 | $15.4M | Sell |
76,803
-363
| -0.5% | -$72.6K | 0.22% | 96 |
|
|
2022
Q2 | $11.3M | Sell |
77,166
-2,796
| -3% | -$408K | 0.11% | 189 |
|
|
2022
Q1 | $13.1M | Buy |
79,962
+4,222
| +6% | +$690K | 0.11% | 199 |
|
|
2021
Q4 | $12.9M | Hold |
75,740
| – | – | 0.1% | 205 |
|
|
2021
Q3 | $14.3M | Buy |
75,740
+18,882
| +33% | +$3.57M | 0.12% | 177 |
|
|
2021
Q2 | $9.64M | Buy |
56,858
+49,900
| +717% | +$8.46M | 0.08% | 168 |
|
|
2021
Q1 | $983K | Hold |
6,958
| – | – | 0.01% | 511 |
|
|
2020
Q4 | $905K | Hold |
6,958
| – | – | 0.01% | 509 |
|
|
2020
Q3 | $1.01M | Hold |
6,958
| – | – | 0.01% | 470 |
|
|
2020
Q2 | $1.03M | Buy |
+6,958
| New | +$1.03M | 0.01% | 459 |
|
|
2015
Q4 | – | Sell |
-276,572
| Closed | -$22.2M | – | 151 |
|
|
2015
Q3 | $22.2M | Buy |
+276,572
| New | +$22.2M | 0.39% | 68 |
|